Alzheimer’s Disease and Cannabinoid Care
Continued Education Session | CNNC 2021
ECS, AD, Dosing, Cannabinoids, Terpenes, Integrative Medicine
What is the ECS answer to neurodegeneration?
Explanation of the incidence and prevalence of AD, the stages, and conventional medicine approach. Compare the research on various facets of the endocannabinoid system and alzheimer’s disease, including dosing strategies to accomplish better patient outcomes to slow progression and ease care.
Understand Alzheimer's Disease, and how to modulate the ECS for better care.